TRANSFORMING TRIPLE-NEGATIVE BREAST CANCER TREATMENT THROUGH INTRATUMORAL IMMUNOTHERAPY VIA NANOFLUIDIC DRUG-ELUTING SEED

The Methodist Hospital Research Institute, Houston TX

Investigators